ADC rush
Big Pharma is inundating the market with acquisitions and alliances for antibody-drug conjugates (ADCs). We reported on the background to this in two separate articles.
https://miyata-bio.net/column/0000342/
Big Pharma is inundating the market with acquisitions and alliances for antibody-drug conjugates (ADCs). We reported on the background to this in two separate articles.
https://miyata-bio.net/column/0000342/